Highres Biosolutions
Highres Biosolutions, a leading innovator in the life sciences sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced automation solutions for drug discovery and biological research. Highres Biosolutions offers a unique range of products, including high-throughput screening systems and integrated laboratory automation platforms, designed to enhance efficiency and accuracy in scientific workflows. Their commitment to precision and innovation has garnered recognition within the industry, positioning them as a trusted partner for pharmaceutical and biotechnology companies. With a focus on improving research outcomes, Highres Biosolutions continues to push the boundaries of technology in the life sciences arena.
DitchCarbon Score
How does Highres Biosolutions's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Highres Biosolutions's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Highres Biosolutions's reported carbon emissions
HighRes Biosolutions, headquartered in the United States, has made significant commitments towards reducing its carbon emissions, although specific emissions data is currently unavailable. The company is actively engaged in climate initiatives, with a near-term target status classified as "Committed" as of January 2024. HighRes Biosolutions has not yet set a net-zero target but has established long-term targets, indicating a proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company is not part of the Science Based Targets initiative (SBTi) but is committed to reducing its carbon footprint in alignment with industry standards. As of now, there are no emissions figures to report, but the company's commitment to climate action reflects a growing trend in the industry towards accountability and transparency in environmental impact. HighRes Biosolutions is positioned to contribute positively to climate goals as it develops and implements its reduction strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Highres Biosolutions is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
